What question did this study set out to answer?

The aim is to enhance follicle-associated delivery of minoxidil and finasteride while minimizing systemic exposure for treating androgenetic alopecia.

August 13, 2026Journal of NanobiotechnologyOpen Access

Cationic nanoemulsions enable follicle-associated delivery with reduced systemic exposure for combined minoxidil/finasteride therapy against androgenetic alopecia

View Full Paper

Ask AI

Bookmark

Discussion

Member takes

Implication

Randomized trial demonstrates effective hair regeneration in androgenetic alopecia, suggesting improved therapy safety and efficacy.

Key Points

The aim is to enhance follicle-associated delivery of minoxidil and finasteride while minimizing systemic exposure for treating androgenetic alopecia.
Formulated a cationic polymer-coated nanoemulsion with minoxidil and finasteride.
Tested efficacy in testosterone-induced AGA mouse models.
Compared performance with commercial minoxidil tincture and single-drug formulations.
Cationic nanoemulsion achieved 90.46% encapsulation for minoxidil and 92.44% for finasteride.
Significantly promoted hair regeneration by inhibiting 5α-reductase and activating β-catenin and VEGF pathways in mouse models.
Showed good skin compatibility with no evident toxicity after repeated applications.

Cite This Study

A 2026 study studied this question.

synapsesocial.com/papers/6a7d75f62b0e0cff3f63ef78 https://doi.org/10.1186/s12951-026-04902-4

View Full Paper

Ask AI

Bookmark

Cationic nanoemulsions enable follicle-associated delivery with reduced systemic exposure for combined minoxidil/finasteride therapy against androgenetic alopecia

Discussion

Member takes

Implication

Key Points

Cite This Study

Cationic nanoemulsions enable follicle-associated delivery with reduced systemic exposure for combined minoxidil/finasteride therapy against androgenetic alopecia

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider